These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 21861641)

  • 1. An evaluation of bioactive glass in the treatment of periodontal defects: a meta-analysis of randomized controlled clinical trials.
    Sohrabi K; Saraiya V; Laage TA; Harris M; Blieden M; Karimbux N
    J Periodontol; 2012 Apr; 83(4):453-64. PubMed ID: 21861641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pretreatment clinical parameters on bioactive glass implantation in intrabony periodontal defects.
    Park JS; Suh JJ; Choi SH; Moon IS; Cho KS; Kim CK; Chai JK
    J Periodontol; 2001 Jun; 72(6):730-40. PubMed ID: 11453234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of a biphasic calcium composite grafting material in the treatment of human periodontal intrabony defects: a 12-month randomized controlled clinical trial.
    Stein JM; Fickl S; Yekta SS; Hoischen U; Ocklenburg C; Smeets R
    J Periodontol; 2009 Nov; 80(11):1774-82. PubMed ID: 19905932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a bioactive glass alloplast in treating periodontal intrabony defects.
    Ong MM; Eber RM; Korsnes MI; MacNeil RL; Glickman GN; Shyr Y; Wang HL
    J Periodontol; 1998 Dec; 69(12):1346-54. PubMed ID: 9926764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical treatment of periodontal intrabony defects with calcium sulfate implant and barrier versus collagen barrier or open flap debridement alone: a 12-month randomized controlled clinical trial.
    Paolantonio M; Perinetti G; Dolci M; Perfetti G; Tetè S; Sammartino G; Femminella B; Graziani F
    J Periodontol; 2008 Oct; 79(10):1886-93. PubMed ID: 18834243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 5-year clinical and radiological study.
    Mengel R; Schreiber D; Flores-de-Jacoby L
    J Periodontol; 2006 Oct; 77(10):1781-7. PubMed ID: 17032123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year results of a prospective, randomized, controlled study evaluating treatment of intra-bony defects with a natural bone mineral and GTR.
    Sculean A; Schwarz F; Chiantella GC; Donos N; Arweiler NB; Brecx M; Becker J
    J Clin Periodontol; 2007 Jan; 34(1):72-7. PubMed ID: 17243997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 12-month clinical and radiological study.
    Mengel R; Soffner M; Flores-de-Jacoby L
    J Periodontol; 2003 Jun; 74(6):899-908. PubMed ID: 12887004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study.
    Froum SJ; Weinberg MA; Rosenberg E; Tarnow D
    J Periodontol; 2001 Jan; 72(1):25-34. PubMed ID: 11210070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of an enamel matrix protein derivative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans.
    Sculean A; Barbé G; Chiantella GC; Arweiler NB; Berakdar M; Brecx M
    J Periodontol; 2002 Apr; 73(4):401-8. PubMed ID: 11990441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of intrabony defects by different surgical procedures. A literature review.
    Laurell L; Gottlow J; Zybutz M; Persson R
    J Periodontol; 1998 Mar; 69(3):303-13. PubMed ID: 9579616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictability of clinical outcomes following regenerative therapy in intrabony defects.
    Aichelmann-Reidy ME; Reynolds MA
    J Periodontol; 2008 Mar; 79(3):387-93. PubMed ID: 18315419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of bovine-derived anorganic bone associated with guided tissue regeneration in intrabony defects. Six-month evaluation at re-entry.
    Batista EL; Novaes AB; Simonpietri JJ; Batista FC
    J Periodontol; 1999 Sep; 70(9):1000-7. PubMed ID: 10505802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of calcium sulfate and autogenous bone graft to bioabsorbable membranes plus autogenous bone graft in the treatment of intrabony periodontal defects: a split-mouth study.
    Orsini M; Orsini G; Benlloch D; Aranda JJ; Lazaro P; Sanz M; De Luca M; Piattelli A
    J Periodontol; 2001 Mar; 72(3):296-302. PubMed ID: 11327056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guided tissue regeneration for the treatment of periodontal intrabony and furcation defects. A systematic review.
    Murphy KG; Gunsolley JC
    Ann Periodontol; 2003 Dec; 8(1):266-302. PubMed ID: 14971257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing treatment outcomes in mandibular Class II furcation defects.
    Tsao YP; Neiva R; Al-Shammari K; Oh TJ; Wang HL
    J Periodontol; 2006 Apr; 77(4):641-6. PubMed ID: 16584345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of bioactive glass in the treatment of periodontal intrabony defects.
    Han J; Meng H; Xu L
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 May; 37(3):225-7. PubMed ID: 12419152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guided tissue regeneration for periodontal infra-bony defects.
    Needleman IG; Worthington HV; Giedrys-Leeper E; Tucker RJ
    Cochrane Database Syst Rev; 2006 Apr; (2):CD001724. PubMed ID: 16625546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of combined regenerative treatments in human mandibular class II furcation defects.
    Santana RB; de Mattos CM; Van Dyke T
    J Periodontol; 2009 Nov; 80(11):1756-64. PubMed ID: 19905945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four-year results of a prospective-controlled clinical study evaluating healing of intra-bony defects following treatment with an enamel matrix protein derivative alone or combined with a bioactive glass.
    Sculean A; Pietruska M; Arweiler NB; Auschill TM; Nemcovsky C
    J Clin Periodontol; 2007 Jun; 34(6):507-13. PubMed ID: 17451415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.